EDGAR Filing Documents for 0001564590-15-004974

Form 8-K - Current report:

SEC Accession No. 0001564590-15-004974

Filing Date

2015-06-10

Accepted

2015-06-10 06:10:30

Documents

Period of Report

2015-06-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ctic-8k_20150609.htm	8-K	60465
2	EX-4.1	ctic-ex41_201506096.htm	EX-4.1	129755
3	EX-10.1	ctic-ex101_201506097.htm	EX-10.1	83852
	Complete submission text file	0001564590-15-004974.txt		275484

Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121

Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100

CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)